Burton, Dennis R <br/><br/>
Public health. A sound rationale needed for phase III HIV-1 vaccine trials.  [electronic resource] 

 -  Science (New York, N.Y.)  Jan 2004 
 - 316 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.1094620  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Clinical Trials, Phase III as Topic--economics<br/>Costs and Cost Analysis<br/>HIV Envelope Protein gp120--immunology<br/>HIV Infections--immunology<br/>HIV-1--immunology<br/>Humans<br/>Immunization Schedule<br/>Immunization, Secondary<br/>T-Lymphocytes, Cytotoxic--immunology<br/>T-Lymphocytes, Helper-Inducer--immunology<br/>Thailand<br/>United States<br/>Vaccines, Synthetic--immunology